Article Type
Review
Subject Area
Microbiology
Abstract
In terms of focus, promising results obtained from extensive investigations showed that the biodiversity of marine invertebrates has been documented. This poses the marine ecosystem as a hopeful resource in the discovery of novel compounds, with an ideal starting point in scaffolding additional screening of marine natural products (MNPs), especially to face the rise in the burden of diseases and treatment failure. A wide range of antimicrobial, antiviral, anticancer, anti-inflammatory, antiparasitic, neuroprotective, analgesic, antimalarial and other agents of marine origin have been pursued in the control and management of diseases. In the current review, we will focus on figuring out drugs from well-known marine species within invertebrates (e.g., sea stars, sea sponges, sea cucumbers, sea urchins, sea worms, soft corals, sea hares, and sea worms). Moreover, we will discuss the current status and challenges being faced in the marine drug discovery field, the investment in the marine bio-drug sector, and how it provides the market with novel products for treating numerous human diseases
Full Text of Submission
wf_yes
Recommended Citation
Ibrahim, Hassan A.H.; Abdelnaby, Hanan M.; Abouelkheir, Samia S.; Abo-Taleb, Hamdy A.; and Sersy, Nermeen A. El
(2023)
"Blue economic potency of marine invertebrates for bio-drug discovery,"
Blue Economy: Vol. 1
:
Iss.
2
, Article 5.
Available at:
https://doi.org/10.57241/2805-2994.1008
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
